Oral Sirolimus for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome,JAMA Ophthalmology

当前位置： X-MOL 学术 › JAMA Ophthalmol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Oral Sirolimus for Diffuse Choroidal Hemangioma in Sturge-Weber Syndrome
JAMA Ophthalmology ( IF 8.1 ) Pub Date : 2024-04-18 , DOI: 10.1001/jamaophthalmol.2024.0854
Amy Kalantary ₁ , Anne Halbert ₂ , Maria Franchina _{2,

3} , Rachael C. Heath Jeffery _{1,

3,

4} , Rod O’Day _{4,

5} , Fred K. Chen _{1,

2,

3,

4,

5}

Affiliation

This case report describes an 8-year-old girl who received oral sirolimus as an adjuvant therapy for pulse dye laser of her port-wine stain and as an off-label treatment of exudative retinal detachment secondary to diffuse choroidal hemangioma.

中文翻译：